Executives and guests of Covidien
(NYSE: COV) will visit the New York Stock Exchange to celebrate the launch of the HOPE (Heart, Obesity, Prevention & Education) Program for former National Football League (NFL) players.
The HOPE Program is a comprehensive obesity research initiative designed to promote healthy lifestyles and weight-management among former professional football players. These former players, when compared to smaller-sized men, are more likely to have cardiovascular problems and other health issues associated with being overweight.
Covidien is dedicated to the wellness and education of patients along the continuum of care, from discovery to treatment, to drive the resolution of medical conditions that accompany obesity. Research indicates that men, who represent a growing portion of the obese population, are reluctant to seek help for weight concerns and are underrepresented in obesity and weight-loss research. This collaboration hopes to raise awareness of obesity treatment options and create higher patient acceptance and adoption of bariatric surgery.
As part of the HOPE Program, former NFL players in certain areas are invited to undergo a comprehensive health screening performed by physicians associated with a local hospital and the Living Heart Foundation, a non-profit organization dedicated to promoting health services to specific groups that have been traditionally overlooked – including high school, college and professional athletes, as well as underserved populations.
The initial consultation assesses baseline weight and overall cardiovascular health, and includes testing for many of the conditions associated with being overweight and obese, including type 2 diabetes. Participants are asked to track their food intake, exercise and weight-loss during the 6-month program. Participants attend 18 group sessions that focus on skills and strategies for successful weight management. At the conclusion of the study, players who do not reach their target health and weight-loss goals will be counseled on potentially pursuing additional medical treatments, including bariatric surgery.
The first HOPE Program screenings occurred in October 2012 at Temple University Hospital under the leadership of Gary Foster, PhD, Director of the Center for Obesity Research and Education at Temple University School of Medicine.
To mark the official launch of the program, Chris Barry, President of Advanced Surgical Technologies, Covidien will ring the NYSE Closing Bell on January 31. He will be joined by Dr. Foster; Henry Buchwald, M.D.; Greg Murphy, former NFL player and HOPE participant; Corey Louchiey, President of New York/New Jersey chapter of the NFL Players Association; and other Covidien employees.
About Covidien (NYSE: COV)
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Thursday, January 31, 2013
NYSE Security Checkpoint/Tent at corner of Exchange Place and Broad Street
3:30 p.m. Media escorted into the building for bell ringing
4:00 p.m. The Closing Bell rings
Media interested in covering the bell ringing MUST contact Annmarie Gioia at 212.656.5437 or email@example.com.
Photos available via Associated Press/New York (212.621.1902), Reuters America (646.223.6285), Getty Images (646.613.4141), Bloomberg Photo (212.617.3420), European Press Agency (917.670.1323), and Insider Images. The Closing Bell (starting at 3:55 p.m.) feed is available via Encompass loop #4009. Media seeking footage via The Switch should contact NYSE Broadcast at 212.656.5483.
For photos and video of the bell ringing, connect with NYSE Euronext on Facebook (NYSE Euronext), YouTube (nysetv1), and Twitter (@NYSEEuronext), #NYSEBell.